2022
DOI: 10.1080/00981389.2022.2060422
|View full text |Cite
|
Sign up to set email alerts
|

Mental health care needs in cystic fibrosis: A scoping review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 32 publications
0
1
0
Order By: Relevance
“…However, in QCA models, it was observed that one of the predictor variables of high and low levels of anxious-depressive symptomatology was the adolescent's quality of life. This would be in line with findings from other studies (Graziano et al, 2020;Tickner et al, 2022). Quality of life was negatively associated with anxious symptomatology but not with depression.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…However, in QCA models, it was observed that one of the predictor variables of high and low levels of anxious-depressive symptomatology was the adolescent's quality of life. This would be in line with findings from other studies (Graziano et al, 2020;Tickner et al, 2022). Quality of life was negatively associated with anxious symptomatology but not with depression.…”
Section: Discussionsupporting
confidence: 92%
“…Previous studies on CF indicate that symptoms of anxiety and depression are two to three times more frequent among CF patients than in the general population (O'Hayer et al, 2021). These symptoms are associated with decreased adherence to treatment, reduced lung function (Smith et al, 2016), poorer health-related quality of life and healthcare costs (Graziano et al, 2020;Tickner et al, 2022). However, despite significant recent medical progress affecting CF, there is a lack of research on the impact on mental health in patients with CF or PCD.…”
mentioning
confidence: 99%
“…Most individuals with CF spend approximately 2–3 h per day on maintenance therapies to prevent lung infections, promote food absorption, and manage the multisystem issues that result from CF (Sawicki et al, 2009). Multiple studies have reported the experiences of individuals living with CF, exploring how intense therapy regimens, physical limitations, and disease progression limit quality of life, leading to increased mental distress, anxiety, and depression (Bathgate et al, 2022; Guta et al, 2021; Lord et al, 2023; Tickner et al, 2022). These psychosocial challenges diminish motivation to adhere to burdensome therapies, which can lead to worsening health outcomes (Havermans & Willem, 2019; Knudsen et al, 2016; Quittner et al, 2014; Sawicki et al, 2009; Smith et al, 2010; Trandel et al, 2019).…”
mentioning
confidence: 99%